Navigation Links
Flexan Expands China Manufacturing to Meet Global Demand for Rubber Molding

Flexan, a leading custom molded rubber manufacturer, announced that it has expanded its China manufacturing capabilities by adding new technology and moving into its second building in the Suzhou Industrial Park, located 45 miles outside of Shanghai. The 50,000-square-foot building provides room for growth in production of custom rubber molding for its international client base. Flexan continues to operate its original 35,000-square-foot production facility nearby, which opened in 2004.

Flexan’s China manufacturing facility provides three areas of specialized rubber molding:

  • Micro-molding for hearing aid and acoustic technology
  • Cleanroom silicone molding for medical devices by its FMI Medical Silicone Molding division
  • Rubber molding for industrial applications such as miniature pneumatics, CNG/LNG/LPG alternative fuels, and automotive and heavy trucks

Flexan also provides value-added operations such as sub-assembly, packaging and kitting.

The China facility serves primarily North American and European clients with operations and markets in the Asia-Pacific region.

“The opportunities for businesses of all kinds to grow in China and the Asia-Pacific region are enormous, despite the recent slowing in China’s growth rate,” observes Bruce Cohen, president of Flexan Corp. “Flexan has added capacity in order to support our manufacturing clients that serve Asian countries where the middle class is expanding rapidly and pushing up consumer demand, such as Malaysia and Vietnam, as well as China.”

Flexan established the China manufacturing operation to provide the same high level of new product development, materials handling, and production as its U.S. facility in Chicago, which allows customers to choose either or both locations for rubber molding. Both facilities are ISO 9000:2008 certified, with English-speaking management and technical staff in China, as well as engineering and project management support in the U.S. The FMI silicone molding facilities in the U.S. and China are each ISO 13485 registered for medical devices with high-level cleanroom operations.

Flexan operates in China as a Wholly Foreign Owned Enterprise (WFOE) with sole U.S. ownership. The Suzhou Industrial Park is a joint venture between Singapore and the Chinese government, which opened in 1994.

Founded in 1946, Flexan is a leading global manufacturer of high-precision elastomer parts that are critical components in a broad array of products and industry applications. Headquartered in Chicago, Flexan has over 500 employees and three manufacturing facilities, and operates two distinct but complementary business units: FMI and Flexan. FMI delivers clean-room manufactured silicone rubber molded components for use in Class II disposable and Class III implantable medical devices. Flexan is a custom molder whose expertise in molding difficult geometries and bonding rubber to metal has earned the company the reputation as an innovative provider across numerous healthcare and industrial markets. For more information, please visit and

Read the full story at

Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related biology technology :

1. Defying Industry Trends, BBK Worldwide Expands Ownership From Within
2. Leading Chemical Manufacturer Expands Biobased Offering through Unique Distribution of Proven Green Spill Absorbent
3. Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
4. GLM Displays Expands Its Line of Formulate Fabric Displays with the Vibe 10ft Display
5. GenoSpace Expands Its Management Team by Appointing Daniel Meyer as Chief Financial Officer
6. Rocky Mountain Biologicals Expands Custom Serum Filtration Facility
7. Julabo USA Inc. Expands Its Line of Compact and Economic Cooling Circulators
8. Cellular Dynamics International Expands MyCell Products Line with Disease Models, Genetic Engineering Patents
9. Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma
10. DoctorDirectory Expands Team for IncreaseRx
11. PharmSource CMO-CDMO Database Expands Coverage to Include Approved Pharmaceutical Products: Intelligence Resource for Analyzing Bio/Pharmaceutical Contract Manufacturing
Post Your Comments:
(Date:2/11/2020)... ... February 11, 2020 , ... ... solutions services in North America, today announced that the City of Fort Worth ... its biosolids management needs. Commencing in April of 2020, Synagro will assume operation ...
(Date:2/3/2020)... and CAMBRIDGE, Mass. (PRWEB) , ... February 03, ... ... Budapest with US offices in Cambridge, MA, announce that OmniType, the 11-locus, single ... (EAP) from today. OmniType is a best-in-class product featuring locus-multiplexing and short library ...
(Date:1/27/2020)... ... January 27, 2020 , ... ... has secured financing from strategic investors led by Halma plc , a ... investors Sonion, TDF Ventures, GII LLC, and WSJ Joshua Fund. A representative from ...
(Date:1/22/2020)... ... January 20, 2020 , ... ... partnership with WAVE Electronics, the largest independent electronics distributor in the US, to ... Brilliant Smart Home Systems with leading smart home products from a single fulfillment ...
Breaking Biology Technology:
(Date:2/5/2020)... ... February 04, 2020 , ... Crystal Diagnostics (CDx) ... a second patent related to proprietary liquid crystal technology for rapid and accurate ... the USPTO issued on December 3, 2019. Together, these patents protect the company’s ...
(Date:1/29/2020)... STATE COLLEGE, Pa. (PRWEB) , ... January 29, ... ... leader in nuclear receptor and in vitro toxicology testing solutions, has announced a ... Shareholders in the upcoming weeks, INDIGO showed more than a twenty percent increase ...
(Date:1/27/2020)... , ... January 27, 2020 , ... ... Chairman. Thorne is a noted investor, tech entrepreneur, and former senior management consultant ... Chairman of Broadline Capital, the global alternative investment firm. , “Chris Thorne ...
Breaking Biology News(10 mins):